Zum Inhalt springen
· Dermal Fillers
SKU 10916

MaiLi Volume

In stock
Volume
4 x 1 mL
Laboratory
Sinclair Pharma
Origin
Schweiz
Indication
Facial volume restoration and structural correction
Treatment areas
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.

MaiLi Volume is an injectable hyaluronic acid dermal filler manufactured by Sinclair Pharma in Switzerland, part of the MaiLi HA filler range. As a MaiLi Volume filler, it is a hyaluronic acid gel cross-linked with BDDE that adds volume to the face, restores facial fullness and corrects deep facial skin depressions. The product contains lidocaine 3 mg/mL for a more comfortable injection experience, is injected into the subcutaneous fat tissue or supraperiosteal zone, is supplied as four 1 mL syringes with four 27G x 1/2" needles, and is intended strictly for professional use.

Key Benefits of MaiLi Volume

  • Adds volume to the face and helps restore facial fullness
  • Suitable for deep facial skin depressions
  • Facial reconstruction of structural defects, including HIV-associated lipoatrophy
  • Cross-linked hyaluronic acid 21 mg/mL with lidocaine 3 mg/mL for injection comfort
  • Hyaluronic acid cross-linked with BDDE
  • Injected into the subcutaneous fat or supraperiosteal zone by trained specialists
  • CE-marked medical device (CE 2797)
Key Information
Brand MAILI
Manufacturer Sinclair Pharma
Country of Origin Switzerland
Certification CE-marked medical device, CE 2797
Ingredients Cross-linked (BDDE) hyaluronic acid 21 mg/mL, biofermentative origin, with lidocaine hydrochloride 3 mg/mL, in phosphate buffer
Packaging Four 1 mL pre-filled syringes, with four single-use 27G x 1/2" needles
Use Type Professional use only - injectable dermal filler with anaesthetic, for facial volume restoration and deep skin depressions
Injection Depth Subcutaneous fat tissue or supraperiosteal zone; reserved to specialists trained in these injection techniques
Protocol / Duration Fully resorbed over time; how long the effect lasts depends on the quantity injected, the depth of placement and the patient's metabolism.

Indications and Professional Use

Main indications

  • Facial volumising and volume restoration
  • Deep facial skin depressions
  • Facial reconstruction of structural defects, including congenital or medically related defects
  • Volume loss due to HIV-associated lipoatrophy

Professional use

MaiLi Volume is for use by authorised healthcare professionals only, injected into the subcutaneous fat tissue or the supraperiosteal zone - reserved to specialists specifically trained in these injection techniques. Composition: cross-linked (BDDE) hyaluronic acid 21 mg/mL of biofermentative origin, with lidocaine hydrochloride 3 mg/mL, in phosphate buffer. Supplied as four 1 mL pre-filled syringes with four 27G x 1/2" needles. Contraindicated in: known hypersensitivity to hyaluronic acid, lidocaine or amide-type local anaesthetics; history of severe allergy or anaphylaxis; autoimmune disease; porphyria; cutaneous disorders, inflammation or infection at or near the treatment site; bleeding disorders or treatment with thrombolytics or anticoagulants; tendency to keloid or hypertrophic scarring; pregnancy or breastfeeding; children.

Treatment areas

  • Face

Patient profile

Suitable for adult patients seeking facial volume restoration, correction of deep facial depressions, or reconstruction of structural defects including volume loss from HIV-associated lipoatrophy, as assessed by a qualified practitioner. Not for use in patients with hypersensitivity to hyaluronic acid, lidocaine or amide anaesthetics; autoimmune disease; porphyria; bleeding disorders or anticoagulant therapy; a tendency to keloid or hypertrophic scarring; or during pregnancy or breastfeeding, and not for children. Injection into the subcutaneous fat or supraperiosteal zone is reserved to specialists specifically trained in these techniques.

How MaiLi Volume Works

MaiLi Volume is a cross-linked hyaluronic acid gel of biofermentative origin, cross-linked with BDDE, containing hyaluronic acid at 21 mg/mL with lidocaine hydrochloride 3 mg/mL to reduce discomfort during injection. It is injected into the subcutaneous fat tissue or the supraperiosteal zone by an authorised healthcare professional trained in these techniques, using the supplied 27G x 1/2" needle, to correct deep facial skin depressions and augment facial tissue volume. The gel creates volume that corrects facial anatomy and is fully resorbed over time; how long the effect lasts depends on the quantity injected, the depth of placement and the patient's metabolism.

Why Order From Allpara

Allpara offers genuine, verified MAILI products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.

Frequently Asked Questions

Which areas can be treated with MaiLi Volume?

The face, for augmentation of facial tissue volume and correction of deep skin depressions, and reconstruction of structural defects including volume loss from HIV-associated lipoatrophy. It is injected into the subcutaneous fat or supraperiosteal zone.

How does MaiLi Volume differ from MaiLi Extreme?

Both are injected into the subcutaneous fat or supraperiosteal zone and contain lidocaine 3 mg/mL. The difference is hyaluronic acid concentration: MaiLi Volume is 21 mg/mL, positioned for facial volume restoration and deep depressions; MaiLi Extreme is 24 mg/mL, the most volumising in the range, positioned for stronger structural volume restoration.

At what depth is MaiLi Volume injected?

Into the subcutaneous fat tissue or the supraperiosteal zone, by a specialist trained in these techniques.

/ Specifications

The datasheet

Category
Dermal Fillers
Brand
MAILI
Laboratory
Sinclair Pharma
SKU
10916
Format
4 x 1 mL
Origin
Schweiz
Indication
Facial volume restoration and structural correction
Use
Professional dermal filler with lidocaine
Treatment areas
/ Product details

The full file

MaiLi Volume is an injectable hyaluronic acid dermal filler manufactured by Sinclair Pharma in Switzerland, part of the MaiLi HA filler range. As a MaiLi Volume filler, it is a hyaluronic acid gel cross-linked with BDDE that adds volume to the face, restores facial fullness and corrects deep facial skin depressions. The product contains lidocaine 3 mg/mL for a more comfortable injection experience, is injected into the subcutaneous fat tissue or supraperiosteal zone, is supplied as four 1 mL syringes with four 27G x 1/2" needles, and is intended strictly for professional use.

Sinclair Pharma, country of origin Schweiz.

Shipped EU-wide from our EU warehouse, tracked and insured, with 24-72h dispatch. Each unit ships with batch number and expiry, held in EU bond and batch-traceable.

Store to manufacturer specification, away from direct light. Cold-chain is only used where the product requires it.

Net 30 / 60 / 90 day terms* are available to verified accounts on credit approval. Invoicing is supported in EUR, CHF and GBP.

Terms are indicative and confirmed after account review.

Which areas can be treated with MaiLi Volume?

The face, for augmentation of facial tissue volume and correction of deep skin depressions, and reconstruction of structural defects including volume loss from HIV-associated lipoatrophy. It is injected into the subcutaneous fat or supraperiosteal zone.

How does MaiLi Volume differ from MaiLi Extreme?

Both are injected into the subcutaneous fat or supraperiosteal zone and contain lidocaine 3 mg/mL. The difference is hyaluronic acid concentration: MaiLi Volume is 21 mg/mL, positioned for facial volume restoration and deep depressions; MaiLi Extreme is 24 mg/mL, the most volumising in the range, positioned for stronger structural volume restoration.

At what depth is MaiLi Volume injected?

Into the subcutaneous fat tissue or the supraperiosteal zone, by a specialist trained in these techniques.

/ Quick answers

Everything a buyer asks first

Which areas can be treated with MaiLi Volume?
The face, for augmentation of facial tissue volume and correction of deep skin depressions, and reconstruction of structural defects including volume loss from HIV-associated lipoatrophy. It is injected into the subcutaneous fat or supraperiosteal zone.
How does MaiLi Volume differ from MaiLi Extreme?
Both are injected into the subcutaneous fat or supraperiosteal zone and contain lidocaine 3 mg/mL. The difference is hyaluronic acid concentration: MaiLi Volume is 21 mg/mL, positioned for facial volume restoration and deep depressions; MaiLi Extreme is 24 mg/mL, the most volumising in the range, positioned for stronger structural volume restoration.
At what depth is MaiLi Volume injected?
Into the subcutaneous fat tissue or the supraperiosteal zone, by a specialist trained in these techniques.
/ FAQ

Frequently asked

The face, for augmentation of facial tissue volume and correction of deep skin depressions, and reconstruction of structural defects including volume loss from HIV-associated lipoatrophy. It is injected into the subcutaneous fat or supraperiosteal zone.
Both are injected into the subcutaneous fat or supraperiosteal zone and contain lidocaine 3 mg/mL. The difference is hyaluronic acid concentration: MaiLi Volume is 21 mg/mL, positioned for facial volume restoration and deep depressions; MaiLi Extreme is 24 mg/mL, the most volumising in the range, positioned for stronger structural volume restoration.
Into the subcutaneous fat tissue or the supraperiosteal zone, by a specialist trained in these techniques.

More from Sinclair

View laboratory

Clinic alternatives

All products

MaiLi Volume

In stock
Verified-only pricing
Sign in or apply for a B2B account to see your price.
Apply for B2B

MaiLi Volume is an injectable hyaluronic acid dermal filler manufactured by Sinclair Pharma in Switzerland, part of the MaiLi HA filler range. As a MaiLi Volume filler, it is a hyaluronic acid gel cross-linked with BDDE that adds volume to the face, restores facial fullness and corrects deep facial skin depressions. The product contains lidocaine 3 mg/mL for a more comfortable injection experience, is injected into the subcutaneous fat tissue or supraperiosteal zone, is supplied as four 1 mL syringes with four 27G x 1/2" needles, and is intended strictly for professional use.

Key Benefits of MaiLi Volume

  • Adds volume to the face and helps restore facial fullness
  • Suitable for deep facial skin depressions
  • Facial reconstruction of structural defects, including HIV-associated lipoatrophy
  • Cross-linked hyaluronic acid 21 mg/mL with lidocaine 3 mg/mL for injection comfort
  • Hyaluronic acid cross-linked with BDDE
  • Injected into the subcutaneous fat or supraperiosteal zone by trained specialists
  • CE-marked medical device (CE 2797)
Key Information
Brand MAILI
Manufacturer Sinclair Pharma
Country of Origin Switzerland
Certification CE-marked medical device, CE 2797
Ingredients Cross-linked (BDDE) hyaluronic acid 21 mg/mL, biofermentative origin, with lidocaine hydrochloride 3 mg/mL, in phosphate buffer
Packaging Four 1 mL pre-filled syringes, with four single-use 27G x 1/2" needles
Use Type Professional use only - injectable dermal filler with anaesthetic, for facial volume restoration and deep skin depressions
Injection Depth Subcutaneous fat tissue or supraperiosteal zone; reserved to specialists trained in these injection techniques
Protocol / Duration Fully resorbed over time; how long the effect lasts depends on the quantity injected, the depth of placement and the patient's metabolism.

Indications and Professional Use

Main indications

  • Facial volumising and volume restoration
  • Deep facial skin depressions
  • Facial reconstruction of structural defects, including congenital or medically related defects
  • Volume loss due to HIV-associated lipoatrophy

Professional use

MaiLi Volume is for use by authorised healthcare professionals only, injected into the subcutaneous fat tissue or the supraperiosteal zone - reserved to specialists specifically trained in these injection techniques. Composition: cross-linked (BDDE) hyaluronic acid 21 mg/mL of biofermentative origin, with lidocaine hydrochloride 3 mg/mL, in phosphate buffer. Supplied as four 1 mL pre-filled syringes with four 27G x 1/2" needles. Contraindicated in: known hypersensitivity to hyaluronic acid, lidocaine or amide-type local anaesthetics; history of severe allergy or anaphylaxis; autoimmune disease; porphyria; cutaneous disorders, inflammation or infection at or near the treatment site; bleeding disorders or treatment with thrombolytics or anticoagulants; tendency to keloid or hypertrophic scarring; pregnancy or breastfeeding; children.

Treatment areas

  • Face

Patient profile

Suitable for adult patients seeking facial volume restoration, correction of deep facial depressions, or reconstruction of structural defects including volume loss from HIV-associated lipoatrophy, as assessed by a qualified practitioner. Not for use in patients with hypersensitivity to hyaluronic acid, lidocaine or amide anaesthetics; autoimmune disease; porphyria; bleeding disorders or anticoagulant therapy; a tendency to keloid or hypertrophic scarring; or during pregnancy or breastfeeding, and not for children. Injection into the subcutaneous fat or supraperiosteal zone is reserved to specialists specifically trained in these techniques.

How MaiLi Volume Works

MaiLi Volume is a cross-linked hyaluronic acid gel of biofermentative origin, cross-linked with BDDE, containing hyaluronic acid at 21 mg/mL with lidocaine hydrochloride 3 mg/mL to reduce discomfort during injection. It is injected into the subcutaneous fat tissue or the supraperiosteal zone by an authorised healthcare professional trained in these techniques, using the supplied 27G x 1/2" needle, to correct deep facial skin depressions and augment facial tissue volume. The gel creates volume that corrects facial anatomy and is fully resorbed over time; how long the effect lasts depends on the quantity injected, the depth of placement and the patient's metabolism.

Why Order From Allpara

Allpara offers genuine, verified MAILI products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.

Frequently Asked Questions

Which areas can be treated with MaiLi Volume?

The face, for augmentation of facial tissue volume and correction of deep skin depressions, and reconstruction of structural defects including volume loss from HIV-associated lipoatrophy. It is injected into the subcutaneous fat or supraperiosteal zone.

How does MaiLi Volume differ from MaiLi Extreme?

Both are injected into the subcutaneous fat or supraperiosteal zone and contain lidocaine 3 mg/mL. The difference is hyaluronic acid concentration: MaiLi Volume is 21 mg/mL, positioned for facial volume restoration and deep depressions; MaiLi Extreme is 24 mg/mL, the most volumising in the range, positioned for stronger structural volume restoration.

At what depth is MaiLi Volume injected?

Into the subcutaneous fat tissue or the supraperiosteal zone, by a specialist trained in these techniques.

More from Sinclair

View laboratory →

MaiLi Volume is an injectable hyaluronic acid dermal filler manufactured by Sinclair Pharma in Switzerland, part of the MaiLi HA filler range. As a MaiLi Volume filler, it is a hyaluronic acid gel cross-linked with BDDE that adds volume to the face, restores facial fullness and corrects deep facial skin depressions. The product contains lidocaine 3 mg/mL for a more comfortable injection experience, is injected into the subcutaneous fat tissue or supraperiosteal zone, is supplied as four 1 mL syringes with four 27G x 1/2" needles, and is intended strictly for professional use.

Sinclair Pharma, country of origin Schweiz.

Shipped EU-wide from our EU warehouse, 24-72h dispatch, tracked and insured. Each unit ships with batch number and expiry, held in EU bond and batch-traceable. Store to manufacturer specification.

Net 30 / 60 / 90 day terms* for verified accounts on credit approval. Invoicing in EUR, CHF and GBP.

Which areas can be treated with MaiLi Volume?

The face, for augmentation of facial tissue volume and correction of deep skin depressions, and reconstruction of structural defects including volume loss from HIV-associated lipoatrophy. It is injected into the subcutaneous fat or supraperiosteal zone.

How does MaiLi Volume differ from MaiLi Extreme?

Both are injected into the subcutaneous fat or supraperiosteal zone and contain lidocaine 3 mg/mL. The difference is hyaluronic acid concentration: MaiLi Volume is 21 mg/mL, positioned for facial volume restoration and deep depressions; MaiLi Extreme is 24 mg/mL, the most volumising in the range, positioned for stronger structural volume restoration.

At what depth is MaiLi Volume injected?

Into the subcutaneous fat tissue or the supraperiosteal zone, by a specialist trained in these techniques.

* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.